- Affiliate Instructor, Global Health
Select from the following:
Ibrahim had his medical training and training in Clinical Pediatrics at Cairo University. He started his medical research career after joining the staff of the U.S. Navy Medical Research Unit (NAMRU-3) in Cairo where, as a Clinical Epidemiologist, he participated in a number of enteric disease and diarrhea vaccine studies and co-directed the U.S. Military Tropical Medicine Course. During his twelve years at NAMRU-3, Ibrahim also served as a co-chair of the Institutional review Board (IRB). Ibrahim also participated in many Outbreak Investigations through the collaboration of US NAMRU-3 and the Egyptian Ministry of Health. In 2008, Ibrahim joined Novartis Vaccines and Diagnostics in Siena, Italy where he has been working on Influenza Vaccines Development, before he joined the Bill and Melinda Gates Foundation in November 2012. In 2015, Ibrahim joined the faculty of the Institute for Health metrics and Evaluation, at the University of Washington to lead the diarrheal diseases team. Ibrahim is a member of many scientific societies and a reviewer in several medical journals. Ibrahim is now serving as a consultant for the WHO IVB, Vaccine Prioritization Program.
- MBBCh (Cairo University (Egypt))
- MS (University of London (UK))
- Burden of Disease
- Child and Adolescent Health (incl. Pediatrics)
- Child Mortality
- Diarrheal Diseases
- Drug and Vaccine Development
- Immigrants and Refugees
- Infectious Diseases
- Maternal Child Health (incl. Reproductive Health)
- Metrics and Evaluation
- Neglected Diseases, Tropical Medicine (incl. Parasites)
- Trop. Med (incl. Parasites)
Ibrahim Khalil, Richard Walker a, Chad K. Porter, Farzana Muhib, Roma Chilengi, Alejandro Cravioto, Richard Guerrant, Ann-Mari Svennerholm, Firdausi Qadri, Shahida Baqar, Margaret Kosek, Gagandeep Kang, Claudio Lanata, George Armah, Thomas Wierzba, Mateusz Hasso-Agopsowicz, Birgitte Giersing, A. Louis Bourgeois. Enterotoxigenic Escherichia coli (ETEC) vaccines: Priority activities to enable product development, licensure, and global access. Vaccine Volume 39, Issue 31, 13 July 2021
Ibrahim A Khalil, Christopher Troeger, Puja C Rao, et al. Morbidity, mortality, and long-term consequences
associated with diarrhoea from Cryptosporidium infection in children younger than 5 years: a meta-analyses study. Lancet Glob Health. 2018 Jul;6(7):e758-e768. doi: 10.1016/S2214-109X(18)30283-3.
Ibrahim A Khalil, Christopher Troeger, Brigette F Blacker, et al. Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990-201. Lancet Infect Dis
. 2018 Nov;18(11):1229-1240. doi: 10.1016/S1473-3099(18)30475-4. Epub 2018 Sep 25.